feed,title,long_url,short_url
Investors,Sarepta Therapeutics Plummets 23% After Gene Therapy Recipient Dies,https://www.investors.com/news/technology/sarepta-stock-sarepta-therapeutics-elevidys-gene-therapy-death/,https://da.gd/3g1Vkt
ðŸ’°Barrons,Capital One Stock Shrugs Off Antitrust Worry. Citi Expects Deal to Go Ahead.,https://barrons.com/articles/capital-one-stock-shrugs-off-antitrust-worry-citi-expects-deal-to-go-ahead-6724fe73?mod=RTA,https://da.gd/e90WzB
